Silence Therapeutics aims at Takeda with new data in rare blood cancer
Sources (7)
- Stocks surge on major acquisition deals and str... Pluang · 1d ago
- Divesiran Eliminates Need for Phlebotomy in 88% of Patients With Polycythemia Vera Cure Today · 1d ago
- Silence posts mid-stage polycythemia vera win, preps for Phase III FirstWord Pharma · 1d ago
- Divesiran Meets Primary Response End Point in Phlebotomy-Dependent Polycythemia Vera OncLive · 1d ago
- Silence spells out Phase 2 success for gene-silencing drug in rare blood cancer Endpoints News · 1d ago
- Silence brings the noise to Takeda with phase 2 blood cancer win Fierce Biotech · 1d ago
- Silence Therapeutics aims at Takeda with new data in rare blood cancer statnews.com · 1d ago broke it first
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Trump media company announces a massive loss and new turnaround effort
Trump Media & Technology Group reports a second-quarter loss of $238 million amid declining digital assets and falling cryptocurrency values.
Wall Street giants partner with Nvidia on $500bn AI financing deal
A $500 billion AI financing pact linking Nvidia with Wall Street giants is dominating business news today.
Defaults Expose Cracks in High-Flying Private Credit
Private‑credit markets clash with optimism as Bloomberg touts rebounds while WSJ warns loan health is deteriorating.
Volkswagen Atlas Cross Sport (2027)
Volkswagen rolls out a more powerful 2027 Atlas Cross Sport, yet omits hybrid tech and even basic towing capacity.
Lenders scrutinize US data center financing as community opposition builds
Lenders now price community pushback as a credit risk in U.S. data center financing, reshaping investor strategies.
Boeing to Sell 3 Autonomous Flight Subsidiaries
Boeing exits eVTOL market by transferring three autonomous flight units to Archer Aviation, securing a new equity partnership